Self-administration of hospital-based narrowband ultraviolet B (TL-01) phototherapy: a feasibility study in an outpatient setting

Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.

An appraisal of narrowband (TL-01) UVB phototherapy. British Photodermatology Group Workshop Report (April 1996).

In Europe, ultraviolet (UV) B phototherapy is being increasingly used for the treatment of skin disease. While this is in part due to an increased awareness of the cancer risks of photochemotherapy (PUVA) there is also evidence that a ‘new’ UVB phototherapy source (TL-01) is more effective than conventional broadband UVB sources, and is possibly as effective as PUVA. A working party of the Brit...

Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis.

OBJECTIVE To compare the efficacy of narrowband UV-B (TL-01) phototherapy with oral 8-methoxypsoralen photochemotherapy (8-MOP psoralen-UV-A [PUVA]) in patients with chronic plaque psoriasis (CPP). DESIGN Open, randomized, controlled study. SETTING Phototherapy unit in a dermatology hospital. PATIENTS Fifty-four patients with CCP. INTERVENTIONS Patients received whole-body threshold ery...

Successful Short Desensitization Treatment Protocol with Narrowband UVB Phototherapy (TL-01) in Polymorphic Light Eruption.

INTRODUCTION Polymorphic light eruption (PLE) is a common idiopathic photodermatosis that typically presents with pruritic papular or papulovesicular lesions on sun-exposed skin between spring and autumn. In many subjects PLE is mild, and can usually be prevented by the use of broad-spectrum topical sunscreens and a gradual increase in sunlight exposure. However, in some individuals, sunlight e...

An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop Report.

Summary These guidelines for use of narrowband (TL-01) ultraviolet B have been prepared for dermatologists by the British Photodermatology Group on behalf of the British Association of Dermatologists. They present evidence-based guidance for treatment of patients with a variety of dermatoses and photodermatoses, with identification of the strength of evidence available at the time of preparatio...